Cargando…
Can Lycopene Impact the Androgen Axis in Prostate Cancer?: A Systematic Review of Cell Culture and Animal Studies
First-line therapy for advanced or metastatic prostate cancer (PCa) involves the removal of tumor-promoting androgens by androgen deprivation therapy (ADT), resulting in transient tumor regression. Recurrent disease is attributed to tumor adaptation to survive, despite lower circulating androgen con...
Autores principales: | Applegate, Catherine C., Rowles, Joe L., Erdman, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471887/ https://www.ncbi.nlm.nih.gov/pubmed/30875962 http://dx.doi.org/10.3390/nu11030633 |
Ejemplares similares
-
Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis
por: Applegate, Catherine C., et al.
Publicado: (2018) -
Lycopene: A Critical Review of Digestion, Absorption, Metabolism, and Excretion
por: Arballo, Joseph, et al.
Publicado: (2021) -
Lycopene: Redress for Prostate Cancer
por: Pisipati, Sai Venkata Vedavyas, et al.
Publicado: (2012) -
Lycopene and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis
por: Chen, Ping, et al.
Publicado: (2015) -
The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies
por: Kapała, Aleksandra, et al.
Publicado: (2022)